According to the report published by Visiongain, the Transcatheter Embolization & Occlusion Devices market was valued at approximately USD xx billion in 2019. The use of minimally invasive endovascular methods in medicine was expanding tremendously. The surgical treatment of almost any organ disorder has been revolutionized thanks to techniques based on real-time photo instructions for the movement of elastic catheters from a shallow, easily accessible blood vessel to a remote, deep blood vessel. The performance of vascular embolization, a technique in which an occlusive agent is provided by a catheter for blocking flow in a target blood vessel, is a common paradigm in endovascular procedures. Embolization was carried out for several medical conditions, including the blood supply for hemorrhagic stomach ulcer and the eradication of a cancer in the liver. A variety of occlusive arms, including metal bobbins, injectable glues and embolic particles, are presently commercially usable. That class of embolic agent has its respective strengths and weaknesses and is well-suited for different medical specialty scenarios. Embolic particles have been produced and remain the most flexible embolic agent; in fact, they are the ideal platform to provide a highly localized therapeutic transcatheter. In the review, we sum up the present methods in particle synthesis and present the merits of the latest technology, such as microfluidics, with enormous potential to promote personalized particle design.
In order for the manufacture of PVA particles for embolotherapy, the surface of a compressed block of PVA is rasped or rasped; the results are sort through sieves to separate the particles according to their size. The variability of particle size and shape is an annoyance of this process. Too large a particle is too close in a vessel and probably causes ineffective embolization. Alternatively, too small a particle will travel too far and increase the risk of damage to the organ. Last cases include facial nerve palsy after existing carotid artery embolism and tissue necrosis after pelvic embolization, from original formulations of PVA. In fact, PVA molecules have a strong friction coefficient and can add up. This has two unwanted consequences. First, the particle’s effective size increases considerably, leading to proximal.
Why you should buy Transcatheter Embolization & Occlusion Devices Market Forecast 2020-2030
Particles for endovascular embolization have evolved
Particles for endovascular embolization have evolved from materials such as lead pellets, muscle, fat, autologous blood clot and gelatin sponge to particles comprised of complex polymers with varying biochemical properties which can be modified to carry therapeutic payloads. Currently available particles span a broad spectrum of sizes, shapes, and materials and compose a versatile toolkit applicable to a myriad of disease processes. This toolkit, and by extension the clinical utility and applicability, is poised to expand substantially through emerging technologies that may revolutionize the accuracy and efficacy of particles.
Embolotherapy is a major aspect of Interventional Radiology
Embolotherapy is a major aspect of Interventional Radiology and, as such, there are an increasing number of indications, ongoing research, and new developments. Numerous materials have been used for embolization and, recently, many new embolic agents, and devices have been developed. In this chapter we review the most common materials used in daily practice of most interventional radiologists. In this two-volume textbook, each chapter discusses separately the optimal embolic materials related to the corresponding clinical indications.
With continue advancement in transcatheter technology and operator expertise, all unwanted vascular communication should be amenable to transcatheter embolization
Transcatheter embolization of congenital or acquired superfluous vascular structure has become routine procedures performed by interventional pediatric cardiologists. Embolization procedure is often part of a collaborative effort with cardiac surgeons to palliate complex congenital heart defect, such as in embolizing aortopulmonary collateral arteries in patient with single ventricle physiology. In other cases, the procedure is the definitive treatment as in embolizing coronary artery fistula. Pediatric cardiologists performing embolization procedures should be familiar with available technologies as well as understand the underlying cardiac anatomy and pathophysiology. Some of the technologies are used only by interventional radiologists but may be useful to pediatric cardiologists.
Transcatheter embolization is a safe and effective method to achieve vascular occlusion.
Embolization procedures have been applied in almost every organ system to occlude congenital or acquired vascular anomalies, to control hemorrhage, to palliate neoplasm, and as a preoperative adjunct to minimize intraoperative blood loss. For the purposes of this review, the term embolization refers to the intentional placement of foreign material in vascular lumina in order to provide therapeutic mechanical and/or gradual thrombogenic, proliferative, or inflammatory closure of the blood vessels. Interventional pediatric cardiologists perform a variety of embolization procedures using several devices and materials. This review will describe the embolization technologies commonly used by or useful to pediatric cardiologists. In addition, the concomitant use of several technologies and operator-modified technologies will be illustrated. This review will also discuss a variety of clinical applications of embolization procedures in pediatric cardiology.
What is the future of the Transcatheter Embolization & Occlusion Devices market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 151 page report you will receive the following key information
• View Transcatheter Embolization & Occlusion Devices market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Transcatheter Embolization & Occlusion Devices market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Transcatheter Embolization & Occlusion Devices sector
• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Transcatheter Embolization & Occlusion Devices industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Transcatheter Embolization & Occlusion Devices submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– Application submarket forecast 2020-2030
• Learn about the market prospects for the leading Transcatheter Embolization & Occlusion Devices market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Transcatheter Embolization & Occlusion Devices revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Type Revenue Forecast 2020-2030
– Coil revenue forecast 2020-2030
Pushable Coils revenue forecast 2020-2030
Detachable Coils revenue forecast 2020-2030
Non Coil revenue forecast 2020-2030
Flow Diverting Devices revenue forecast 2020-2030
Embolization Particles revenue forecast 2020-2030
Liquid Embolics revenue forecast 2020-2030
Others revenue forecast 2020-2030
– Application Revenue Forecast 2020-2030
– Peripheral Vascular Disease revenue forecast 2020-2030
Arterial Blockage revenue forecast 2020-2030
Venous Blood clot revenue forecast 2020-2030
Others revenue forecast 2020-2030
Oncology revenue forecast 2020-2030
Liver Cancer revenue forecast 2020-2030
Pancreatic Cancer revenue forecast 2020-2030
Breast Cancer revenue forecast 2020-2030
Kidney Cancer revenue forecast 2020-2030
Others revenue forecast 2020-2030
Neurology revenue forecast 2020-2030
Brain Aneurysm revenue forecast 2020-2030
Cerebral Arteriovenous Malformations revenue forecast 2020-2030
Others revenue forecast 2020-2030
Urology revenue forecast 2020-2030
Benign Prostatic Hyperplasia/Urinary Retention revenue forecast 2020-2030
Others (Varicocele) revenue forecast 2020-2030
Others revenue forecast 2020-2030
• Understand the prospects for the 4 regional and the leading 12 national Transcatheter Embolization & Occlusion Devices markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Transcatheter Embolization & Occlusion Devices companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
• Explore the factors affecting Transcatheter Embolization & Occlusion Devices product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
• Identify who the leading companies are in the Transcatheter Embolization & Occlusion Devices industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Transcatheter Embolization & Occlusion Devices companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Transcatheter Embolization & Occlusion Devices Market
Johnson & Johnson Services, Inc.
Merit Medical Systems
BTG International Ltd
Penumbra, Inc.
Boston Scientific Corporation
Terumo Corporation
Medtronic, Inc.
DePuy Synthes
Stryker Corporation
Cordis Corporation
Discover Information found nowhere else in this independent assessment of the Transcatheter Embolization & Occlusion Devices market
The Transcatheter Embolization & Occlusion Devices Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Transcatheter Embolization & Occlusion Devices sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030.
How the Transcatheter Embolization & Occlusion Devices Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Transcatheter Embolization & Occlusion Devices market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Transcatheter Embolization & Occlusion Devices sector and find out what its future market prospects are.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Transcatheter Embolization & Occlusion Devices Market Forecast 2020-2030: Forecasts and Analysis by Type, by Application, and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Definition
1.2 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Overview
1.3 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Segmentation
1.4 Research Scope of Transcatheter Embolization & Occlusion Devices Report 2020-2030 in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Transcatheter Embolization & Occlusion Devices Report 2020-2030 Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
3. Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Analysis
3.1 PEST Analysis of the Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.2 Supplier Power
3.9.3 Buyer Power
3.9.4 Threat of Substitute
3..9.5 Threat of New Entrant
4. Transcatheter Embolization & Occlusion Devices Report 2020-2030: Global Market Analysis by Segments
4.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, by Type Outlook (Revenue, USD Million, 2015 - 2026) 2020-2030
4.1.1 Type Outlook (Revenue, USD Million, 2015 - 2026) Overview
4.1.2 Coil Market Forecast, 2020-2030
4.1.2.1 Pushable Coils Market Forecast, 2020-2030
4.1.2.2 Detachable Coils Market Forecast, 2020-2030
4.1.3 Non Coil Market Forecast, 2020-2030
4.1.3.1 Flow Diverting Devices Market Forecast, 2020-2030
4.1.3.2 Embolization Particles Market Forecast, 2020-2030
4.1.3.3 Liquid Embolics Market Forecast, 2020-2030
4.1.3.4 Others Market Forecast, 2020-2030
4.1.4 Other Type Outlook (Revenue, USD Million, 2015 - 2026) Market Forecast,2020-2030
4.2 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, by Application Outlook (Revenue, USD Million, 2015 - 2026) 2020-2030
4.2.1 Application Outlook (Revenue, USD Million, 2015 - 2026) Overview
4.2.2 Peripheral Vascular Disease Market Forecast, 2020-2030
4.2.2.1 Arterial Blockage Market Forecast, 2020-2030
4.2.2.2 Venous Blood clot Market Forecast, 2020-2030
4.2.2.3 Others Market Forecast, 2020-2030
4.2.3 Oncology Market Forecast, 2020-2030
4.2.3.1 Liver Cancer Market Forecast, 2020-2030
4.2.3.2 Pancreatic Cancer Market Forecast, 2020-2030
4.2.3.3 Breast Cancer Market Forecast, 2020-2030
4.2.3.4 Kidney Cancer Market Forecast, 2020-2030
4.2.3.5 Others Market Forecast, 2020-2030
4.2.4 Neurology Market Forecast, 2020-2030
4.2.4.1 Brain Aneurysm Market Forecast, 2020-2030
4.2.4.2 Cerebral Arteriovenous Malformations Market Forecast, 2020-2030
4.2.4.3 Others Market Forecast, 2020-2030
4.2.5 Urology Market Forecast, 2020-2030
4.2.5.1 Benign Prostatic Hyperplasia/Urinary Retention Market Forecast, 2020-2030
4.2.5 2 Others (Varicocele)Market Forecast, 2020-2030
4.2.6 Other Application Outlook (Revenue, USD Million, 2015 - 2026) Market Forecast, 2020-2030
5. Leading Regions in Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, 2020-2030
5.2.1 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.2.2 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.2.3 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Forecast 2020-2030
5.2.4 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.2.4.2 Canada Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.2.4.3 Mexico Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, 2020-2030
5.3.1 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.3.2 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.3.3 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Forecast 2020-2030
5.3.4 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.2 Germany Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.3 France Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.4 Italy Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.5 Spain Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.6 The Netherlands Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, 2020-2030
5.4.1 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.4.2 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.4.3 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Forecast 2020-2030
5.4.4 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Country Forecast 2020-2030
5.4.4.1 China Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.2 India Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.3 Japan Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.4 Korea Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.5 Indonesia Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.6 Australia Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, Forecast 2020-2030
5.5 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast, 2020-2030
5.5.1 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.5.2 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
5.5.3 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Forecast 2020-2030
6. Leading Companies in The Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market
6.1 Johnson & Johnson Services, Inc.
6.1.1 Johnson & Johnson Services, Inc. Overview
6.1.2 Analysis of Johnson & Johnson Services, Inc. Products and Services
6.1.3 Johnson & Johnson Services, Inc. Primary Market Competitors 2019
6.1.4 Johnson & Johnson Services, Inc. Key Developments
6.2 Merit Medical Systems
6.2.1 Merit Medical Systems Company Overview
6.2.2 Analysis of Merit Medical Systems Products and Services
6.2.3 Merit Medical Systems Primary Market Competitors 2019
6.2.4 Merit Medical Systems Key Developments
6.3 Merit Medical Systems
6.3.1 Merit Medical Systems Company Overview
6.3.2 Analysis of Merit Medical Systems Products and Services
6.3.3 Merit Medical Systems Primary Market Competitors 2019
6.3.4 Merit Medical Systems Key Developments
6.4 Penumbra, Inc.
6.4.1 Penumbra, Inc. Company Overview
6.4.2 Analysis of Penumbra, Inc. Products and Services
6.4.3 Penumbra, Inc. Primary Market Competitors 2019
6.4.4 Penumbra, Inc. Key Developments
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Company Overview
6.5.2 Analysis of Boston Scientific Corporation Products and Services
6.5.3 Boston Scientific Corporation Primary Market Competitors 2019
6.5.4 Boston Scientific Corporation Key Developments
6.6 Terumo Corporation
6.6.1 Terumo Corporation Company Overview
6.6.2 Analysis of Terumo Corporation Products and Services
6.6.3 Terumo Corporation Primary Market Competitors 2019
6.6.4 Terumo Corporation Key Developments
6.7 Medtronic, Inc.
6.6.1 Medtronic, Inc. Company Overview
6.6.2 Analysis of Medtronic, Inc. Products and Services
6.6.3 Medtronic, Inc. Primary Market Competitors 2019
6.6.4 Medtronic, Inc. Key Developments
6.8 DePuy Synthes
6.8.1 DePuy Synthes Company Overview
6.8.2 Analysis of DePuy Synthes Products and Services
6.8.3 DePuy Synthes Primary Market Competitors 2019
6.8.4 DePuy Synthes Key Developments
6.9 Stryker Corporation
6.9.1 Stryker Corporation Company Overview
6.9.2 Analysis of Stryker Corporation Products and Services
6.9.3 Stryker Corporation Primary Market Competitors 2019
6.9.4 Stryker Corporation Key Developments
6.10 Cordis Corporation
6.10.1 Cordis Corporation Company Overview
6.10.2 Analysis of Cordis Corporation Products and Services
6.10.3 Cordis Corporation Primary Market Competitors 2019
6.10.4 Cordis Corporation Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Segmentation
Figure 2.1 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Value Chain Analysis
Figure 3.1 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Supply-Demand Analysis
Figure 4.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030
Figure 4.3 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market By Type Outlook (Revenue, USD Million, 2015 - 2026) Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.19 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 by Submarket By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($ million)
Figure 4.20 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.21 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, By System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by 2020-2030
Figure 5.3 Leading Country/Regional Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Share, by 2020
Figure 5.4 Leading Country/Regional Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Share, by 2025
Figure 5.5 Leading Country/Regional Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Share, by 2030
Figure 5.6 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Forecast 2020-2030
Figure 5.8 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.9 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.10 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By 2020-2030 ($billion, AGR%)
Figure 5.10 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Forecast 2020-2030
Figure 5.12 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.13 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.14 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Forecast 2020-2030
Figure 5.13 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.17 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Forecast 2020-2030
Figure 5.18 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Forecast 2020-2030
Figure 5.20 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.21 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030
Figure 5.21 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket , By Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Merit Medical Systems Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Merit Medical Systems Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Penumbra, Inc. Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Penumbra, Inc. Revenue % Share, by Segment, 2019
Figure 6.8 Penumbra, Inc. Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Penumbra, Inc. Revenue % Share, by Business Segment, 2019
Figure 6.10 Boston Scientific Corporation Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Terumo Corporation Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Medtronic, Inc. Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Medtronic, Inc. Revenue % Share, by Regional Segment, 2019
Figure 6.14 DePuy Synthes Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 DePuy Synthes Revenue % Share, by Regional Segment, 2019
Figure 6.16 DePuy Synthes Revenue % Share, by Business Segment, 2019
Figure 6.17 Stryker Corporation Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Cordis Corporation Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Cordis Corporation Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Cordis Corporation Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Type Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Transcatheter Embolization & Occlusion Devices Report 2020-2030 Submarket, By Application Outlook (Revenue, USD Million, 2015 - 2026) Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Merit Medical Systems Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Merit Medical Systems Products and Services (Product/Service, Segment)
Table 6.8 Merit Medical Systems Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Merit Medical Systems Total Company Recent Development 2015-2019
Table 6.10 Merit Medical Systems Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Merit Medical Systems Products and Services (Product/Service, Segment)
Table 6.12 Merit Medical Systems Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Merit Medical Systems Total Company Recent Development 2015-2019
Table 6.14 Penumbra, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Penumbra, Inc. Products and Services (Product/Service, Segment)
Table 6.16 Penumbra, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Penumbra, Inc. Total Company Recent Development 2015-2019
Table 6.18 Boston Scientific Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Boston Scientific Corporation Products and Services (Product/Service, Segment)
Table 6.20 Boston Scientific Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Boston Scientific Corporation Total Company Recent Development 2015-2019
Table 6.22 Terumo Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Terumo Corporation Products and Services (Product/Service, Segment)
Table 6.24 Terumo Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Terumo Corporation Total Company Recent Development 2015-2019
Table 6.26 Medtronic, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Medtronic, Inc. Products and Services (Product/Service, Segment)
Table 6.28 Medtronic, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Medtronic, Inc. Total Company Recent Development 2015-2019
Table 6.30 DePuy Synthes Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 DePuy Synthes Products and Services (Product/Service, Segment)
Table 6.32 DePuy Synthes Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 DePuy Synthes Total Company Recent Development 2015-2019
Table 6.34 Stryker Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Stryker Corporation Products and Services (Product/Service, Segment)
Table 6.36 Stryker Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Stryker Corporation Total Company Recent Development 2015-2019
Table 6.38 Cordis Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Cordis Corporation Products and Services (Product/Service, Segment)
Table 6.40 Cordis Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Cordis Corporation Total Company Recent Development 2015-2019
Top Companies
Boston Scientific Corporation
BTG International Ltd
Cordis Corporation
DePuy Synthes
Johnson & Johnson Services, Inc.
Merit Medical Systems
Medtronic, Inc.
Penumbra, Inc.
Stryker Corporation
Terumo Corporation
Other Companies
Cook
Nordian
Pfizer, Inc.
Sirtex medical
St. Jude Medical
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
